Characteristics and study eligibility of British lung cancer patients for clinical trials evaluating targeted therapies (TTS) or immune checkpoint inhibitors (ICIS)

van Veelen, Ard; Abtahi, Shahab; Souverein, Patrick; Driessen, Johanna H. M.; Klungel, Olaf H.; Dingemans, Anne-Marie; van Geel, Robin; de Vries, Frank; Croes, Sander

doi:10.1002/pds.5113-2

Characteristics and study eligibility of British lung cancer patients for clinical trials evaluating targeted therapies (TTS) or immune checkpoint inhibitors (ICIS)

DSpace/Manakin Repository

Characteristics and study eligibility of British lung cancer patients for clinical trials evaluating targeted therapies (TTS) or immune checkpoint inhibitors (ICIS)

van Veelen, Ard; Abtahi, Shahab; Souverein, Patrick; Driessen, Johanna H. M.; Klungel, Olaf H.; Dingemans, Anne-Marie; van Geel, Robin; de Vries, Frank; Croes, Sander

(2020) Utrecht University Repository

Download/Full Text

Open Access version via Utrecht University Repository

DOI: https://doi.org/

See more statistics about this item